ArticlePlastic and reconstructive surgery. Global open2026
Infantile Myofibroma of Scalp.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Infantile myofibroma (IM) is the most common congenital fibrous tumor of infancy, originating from fibroblasts and myofibroblasts and present at birth in approximately 50%-60% of cases. Solitary IMs most often develop in the head and neck, less frequently on the trunk or extremities, and usually have an excellent prognosis in the absence of visceral involvement. Clinically, IM appears as a painless, firm, bluish-purple, freely mobile nodule and may occasionally show ulceration or skin atrophy, clinically mimicking hemangioma. Imaging typically shows well-defined masses with low-flow or peripheral vascularity, distinguishing them from highly vascular hemangiomas. Although solitary lesions may spontaneously regress within 18-24 months, surgical excision is advised when diagnosis is uncertain, functional risk exists, or for cosmetic or psychosocial reasons. Multicentric IM without visceral involvement also has a favorable outcome, whereas lesions with visceral involvement carry significantly higher morbidity and mortality. Mutations in
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.